Icon (MEX:ICLR) Common Stock : MXN137 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Icon Common Stock?

Icon's quarterly common stock increased from Jun. 2024 (MXN123 Mil) to Sep. 2024 (MXN132 Mil) and increased from Sep. 2024 (MXN132 Mil) to Dec. 2024 (MXN137 Mil).

Icon's annual common stock declined from Dec. 2022 (MXN130 Mil) to Dec. 2023 (MXN114 Mil) but then increased from Dec. 2023 (MXN114 Mil) to Dec. 2024 (MXN137 Mil).

Icon Common Stock Historical Data

The historical data trend for Icon's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icon Common Stock Chart

Icon Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Common Stock

Get a 7-Day Free Trial

91.11

136.21

129.63

113.71

137.36

Icon Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Common Stock	Get a 7-Day Free Trial															113.71	111.38	123.11	131.98	137.36

Icon Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Icon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Icon PLC (MEX:ICLR) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

ICLR:USA IJF:Germany

Address

South County Business Park, Leopardstown, Dublin, IRL, D18 X5R3

Website

https://www.iconplc.com

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.